Entry Detail



General Information

Database ID:exR0078035
RNA Name:NUCKS1
RNA Type:mRNA
Chromosome:chr1
Starnd:-
Coordinate:
Start Site(bp):205712822End Site(bp):205750182
External Links:ENSG00000069275



Disease Information

Disease Name:Fragile X Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D005600
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Fragile X Syndromes//Syndrome, Fragile X//Syndromes, Fragile X//Marker X Syndrome//Marker X Syndromes//Syndrome, Marker X//Syndromes, Marker X//Mental Retardation, X-Linked, Associated With Marxq28//X-Linked Mental Retardation and Macroorchidism//X Linked Mental Retardation and Macroorchidism//Fragile X Mental Retardation Syndrome//Martin-Bell Syndrome//Martin Bell Syndrome//Syndrome, Martin-Bell//Fra(X) Syndrome//FRAXE Syndrome//FRAXE Syndromes//Syndrome, FRAXE//Syndromes, FRAXE//Mental Retardation, X-Linked, Associated With Fragile Site Fraxe//Fragile X-F Mental Retardation Syndrome//Mar (X) Syndrome//FRAXA Syndrome//FRAXA Syndromes//Syndrome, FRAXA//Syndromes, FRAXA



Expression Detail

GEO ID:GSE83556
Description:Global transcriptome dysregulation in second trimester fetuses with FMR1 expansions
Experimental Design:Disease vs Control
Case Disease Type:Fragile X Syndrome
Case Disease SubType:NA
Case Sample:Fragile X Syndrome
Control Sample:Normal
Number of Case:22
Number of Control:18
Number of Samples:40





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
ALDOA
chr16
30064164
30070457
+
AFAP1
chr4
7758714
7939926
-
AC068946.2
chr2
219209772
219222738
-
AC015813.2
chr17
57989038
58007246
-
AC091959.3
chr5
146203550
146339251
+
ACTR3
chr2
113890063
113962596
+
AC005832.4
chr12
4604944
4662643
+
ACSS2
chr20
34872146
34927962
+
AC120057.2
chr17
7240427
7244635
-
AGPAT3
chr21
43865223
43987592
+
AC092143.1
chr16
89919165
89936092
+
ALDH7A1
chr5
126531200
126595362
-
ABRACL
chr6
139028745
139043302
+
ABCC1
chr16
15949577
16143074
+
AGPAT1
chr6
32168212
32178096
-
AC010422.3
chr19
12643831
12648397
-
AC058822.1
chr4
53377839
54295272
+
AL136454.1
chr1
192716132
192716653
+
AC020915.5
chr19
58228914
58315183
+
ACTR1A
chr10
102461881
102502712
-
ADAR
chr1
154582057
154628013
-
AKT2
chr19
40230317
40285536
-
AL121594.1
chr14
35122549
35317474
+
ACSL4
chrX
109624244
109733403
-
AC010463.1
chr19
17267418
17282966
+
AFF4
chr5
132875395
132963634
-
AGL
chr1
99850361
99924023
+
AIMP2
chr7
6009255
6023834
+
AHSP
chr16
31527900
31528803
+
AC008982.1
chr19
38817471
38840178
-
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-671-5p
chr7
151238449
151238471
+
hsa-miR-4426
chr1
192716333
192716349
+
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC005005.3
chr22
31082156
31083565
-
AC005899.4
chr17
32328441
32329395
+
AC012368.1
chr2
64143239
64252859
+
AC015522.1
chr8
83912713
84142463
+
AC022784.3
chr8
9255349
9260295
-
AC069281.2
chr7
100572232
100578700
-
AC132217.1
chr11
2129121
2129964
-
AL022311.1
chr22
37876148
37895563
+
Display:



Experiment Detail

GEO ID:GSE83556
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:RNA was extracted from 5-15 mL amniotic fluid supernatant (centrifugation at 350g, 4C, 10, min).
RNA Extract protocol:All samples were processed using the Qiagen Circulating Nucleic Acid kit with an on-column DNase digestion step to remove genomic DNA. The RNA was then purified and concentrated with the RNeasy MinElute Clean up kit and eluted in RNasefree water.
RNA library preparation protocol:RNA was converted to cDNA and amplified using the Ovation Pico WTA kit V2 and then purified with the QIAquick PCR Purification kit. Samples were labeled using the Encore Biotin Module (NuGEN, San Carlos, CA)Samples were labeled using the Encore Biotin Module (NuGEN, San Carlos, CA).



Reference

PMID:NA
Title:NA
Author:NA
Journal:NA
Description:NA